NDAQ:ICCM - Post Discussion
Post by
whytestocks on Apr 15, 2024 12:30pm
IceCure Medical Requests Marketing Authorization to Treat Ea
News; $ICCM IceCure Medical Requests Marketing Authorization to Treat Early-Stage Breast Cancer from FDA2024-04-15 10:06:29 ET DENVER, Colo., Apr 15, 2024 ( 247marketnews.com )- IceCure Medical Ltd. (NASDAQ: ICCM ) stated that it submitted final data to the U.S. Food and Drug Administration (“FDA”) requesting marketing authorization for ProSense, which received the FDA&#...
ICCM - IceCure Medical Requests Marketing Authorization to Treat Early-Stage Breast Cancer from FDA
Be the first to comment on this post